Pharma

The reason for the recall is current Good Manufacturing Practise deviations, USFDA said.

Dr. Reddy's, did not however elaborate on the observations about its drug making facility in Andhra Pradesh.

Shares of Ajanta Pharma were trading 0.35 per cent higher at Rs 1,197.10 on the BSE.

The company has more than 140 approvals and has so far filed over 300 abbreviated new drug applications (ANDAs) since it commenced filings in 2003-04.

Bartering is a form of exchange that enables producers to reduce reliance on bank loans to finance the crop as they receive inputs such as agrochemicals from Bayer.

The lawsuit seeks damages to compensate the class of investors for a 'purported decline' in the company's share price.

Government owns majority stakes in 21 banks and merger of some of them is being considered for broader economic revival.

According to the US drug watchdog - USFDA - as many as 24,652 tablets are being recalled.

The government had in February slashed the maximum price of life-saving heart stent implants by up to 85 per cent.

The introduction of price controls marks the latest step by Prime Minister Narendra Modi's government to make drugs and medical devices more affordable.

Granules India shares ended 8 per cent higher on BSE.

The closing of the deal, which would be China's largest ever acquisition in India if approved, has now been extended to Sept. 26

Due to falling US sales and GST, Dr Reddy's Laboratories net profit fell more than 56 per cent for the June quarter.

North America and Europe account for over 70 per cent of the company's revenue from pharmaceuticals business.

The company's cumulative filings with the USFDA now stand at 368. It has received approvals for 218 products while 150 product filings are pending approval.